Healio Minute Podcast, Neurology Edition: Top Headlines - Week of October 3, 2022
In this edition, lecanemab study shows reduction in clinical decline for early AD; multimorbidity associated with increased risk for dementia, Crenezumab not effective in treating Alzheimer's disease and more.
Read the full coverage here:
Phase 3 study of lecanemab shows reduction in clinical decline in patients with early AD
Multimorbidity associated with increased risk for dementia
Crenezumab not effective in treating Alzheimer's disease
FDA approves macrocyclic GBCA for contrast-enhanced MRI
Healthy habits in midlife may help delay onset of cognitive decline
References:
Calvin CM, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2022.32124.
Ostrowitzki S, et al. JAMA Neurol. 2022;doi:10.1001/jamaneurol.2022.2909.
Small G. What’s preventing us from preventing dementia? Presented at: BRAINWeek; Sept. 28-30, 2022; Las Vegas.
Collapse
Read more about
